Please login to the form below
REGEN-COV
This page shows the latest REGEN-COV news and features for those working in and with pharma, biotech and healthcare.
Roche, Regeneron’s COVID-19 antibody cocktail cuts infection risk
REGEN-COV reduced the risk of symptomatic infections by 81% in a phase 3 prevention trial. ... This includes evaluating REGEN-COV for the treatment of non-hospitalised and certain hospitalised patients.
Latest news
-
Roche, Regeneron’s COVID-19 antibody cocktail cuts hospitalisation or death by 70%
The antibody cocktail also met all key secondary endpoints in the REGN-COV 2067 trial, including the ability to reduce symptom duration by a median of four days. ... A companion phase 2 trial – REGEN-COV 20145 – in low-risk symptomatic or
-
UPDATED: Regeneron’s COVID-19 antibody cocktail shows ‘clear efficacy’
The CHMP's review took place in parallel to the EMA's rolling review of REGEN-COV. ... From now on, the study will continue to enrol patients into both the 1, 200mg and 2, 400mg REGEN-COV treatment groups.
-
Regeneron’s antibody cocktail prevents COVID-19 in high-risk patients
The first exploratory analysis of 400 evaluable participants found that passive vaccination with REGEN-COV resulted in 100% prevention of symptomatic COVID-19 infections. ... On top of that, the cocktail led to approximately 50% lower overall rates of
More from news
Approximately 3 fully matching, plus 1 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Senior Account Director & Associate Director - Healthcare Ad...
-
Highly Competitive Salary, Bonus &Benefits
- FREELANCE Medical Writer, Senior Medical Writer, Principal Medic...
-
Highly Competitive Day Rate, Bonus &Benefits
- Editor & Senior Editor - Medical Communications - Home Based
-
Highly Competitive Salary, Bonus &Benefits
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
- Freelance Account Manager - Creative Healthcare Comms - Immediat...
-
Excellent Day Rate
-
Account Management
-
Competitive Salary Offered
- Client Services Director – London or Home Based – Medical Commun...
-
Highly Competitive Salary, Bonus &Benefits
- Senior Account / Programme Manager - MedComms - Buckinghamshire
-
Highly Competitive Remuneration packages
- Senior Content Editor - Biotechnology
-
Salary TBC
- Freelance Medical Writer - Creative Healthcare Comms - 2 month t...
-
Excellent Day Rate
- Senior Leadership Role – Medical Communications – North West
-
Highly Competitive Salary, Bonus &Benefits
- Medical Writer, Senior Medical Writer, Principal Medical Writer,...
-
Highly Competitive Salary, Bonus &Benefits
- AZ showcases data for next-generation PARP inhibitor AZD5305
- Sanofi pays $160m upfront to acquire Tidal Therapeutics
- GSK discontinues two feladilimab trials in head and neck cancer
- Novavax seeks FDA emergency approval for COVID-19 vaccine by May
- Pfizer/BioNTech say their COVID-19 vaccine can be stored at warmer temperatures
- FDA approves new self-injection administration for Xolair
- Lilly asks to revoke emergency authorisation for bamlanivimab monotherapy in the US
- CureVac outlines COVID-19 vaccine production plans ahead of regulatory approval
- Alexion and NICE agree confidential discount for Ultomiris use on the NHS
- Novartis’ MS therapy Kesimpta reduces risk of disability progression regardless of relapses
- Merck & Co halts development of potential COVID-19 drug MK-7110
- Virtually, the same: Is it time to rethink congress strategy?
PMHub
Anthill Agency
Digital communications agency empowering clients through their digital transformation journey. Whether through training, delivering solutions or devising digital strategies, we...
Latest intelligence
- InSite Events™ National Pharma Meeting: A Customer Story
- How our client leveraged Impetus Digital’s white-glove service, 360° coverage and care, and award-winning InSite Events™ platform to successfully transfer their annual national meeting online....
- Fear or encouragement, which is best to drive behaviour change?
- The communications industry depends on fear of the perceived loss of something, in order to create the hope found in a product benefit. But, if if left too long unchecked,...
- The unheard, unseen, and uncorrected effects of COVID-19
- The disproportionate effects of the pandemic have been highlighted amongst ethnic minorities, so is it likely that ethnic minorities will be more worried about participating? And could this exacerbate inequalities...
Quick links
Infographics
